190 related articles for article (PubMed ID: 22835735)
1. Biologically plausible and evidence-based risk intervals in immunization safety research.
Rowhani-Rahbar A; Klein NP; Dekker CL; Edwards KM; Marchant CD; Vellozzi C; Fireman B; Sejvar JJ; Halsey NA; Baxter R;
Vaccine; 2012 Dec; 31(1):271-7. PubMed ID: 22835735
[TBL] [Abstract][Full Text] [Related]
2. Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.
LaRussa PS; Edwards KM; Dekker CL; Klein NP; Halsey NA; Marchant C; Baxter R; Engler RJ; Kissner J; Slade BA
Pediatrics; 2011 May; 127 Suppl 1():S65-73. PubMed ID: 21502239
[TBL] [Abstract][Full Text] [Related]
3. Adverse events following immunization: real causality and myths.
Principi N; Esposito S
Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
5. Safety monitoring in vaccine development and immunization.
Lee CJ; Lee LH; Lu CH; Huang YJ; Chu ML
Acta Paediatr Taiwan; 2006; 47(1):7-13. PubMed ID: 17016963
[TBL] [Abstract][Full Text] [Related]
6. [Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].
Zhang LP; Yu F; Jin BF; Wang Y; Xu HL; DU Y
Zhonghua Er Ke Za Zhi; 2012 Nov; 50(11):859-64. PubMed ID: 23302620
[TBL] [Abstract][Full Text] [Related]
7. Adverse Events Following Immunization- The Known Unknowns and Black Box : Based on 10th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 9th Oct. 2022.
Das MK
Indian J Pediatr; 2023 Aug; 90(8):817-825. PubMed ID: 37233889
[TBL] [Abstract][Full Text] [Related]
8. Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial.
Tsafack M; Ateudjieu J
Pan Afr Med J; 2015; 22():351. PubMed ID: 26985269
[TBL] [Abstract][Full Text] [Related]
9. Causality assessment of serious and severe adverse events following immunization in India: a 4-year practical experience.
Singh AK; Wagner AL; Joshi J; Carlson BF; Aneja S; Boulton ML
Expert Rev Vaccines; 2018 Jun; 17(6):555-562. PubMed ID: 29865876
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.
Schumacher Z; Bourquin C; Heininger U
Vaccine; 2010 May; 28(24):4059-64. PubMed ID: 20406662
[TBL] [Abstract][Full Text] [Related]
11. Revaccination and Adverse Event Recurrence in Patients with Adverse Events following Immunization.
Muñoz CE; MacDonald B; Pham-Huy A; Vaudry W; Pernica JM; Boucher FD; Constantinescu C; Sadarangani M; Bettinger JA; Tapiéro B; Morris SK; McConnell A; Cowan J; Zafack J; Upton J; Abdurrahman Z; McHenry M; Hildebrand KJ; Noya F; De Serres G; Halperin SA; Top KA;
J Pediatr; 2022 Nov; 250():45-53.e3. PubMed ID: 35948192
[TBL] [Abstract][Full Text] [Related]
12. Vaccine adverse event monitoring systems across the European Union countries: time for unifying efforts.
Zanoni G; Berra P; Lucchi I; Ferro A; O'Flanagan D; Levy-Bruhl D; Salmaso S; Tridente G
Vaccine; 2009 May; 27(25-26):3376-84. PubMed ID: 19200851
[TBL] [Abstract][Full Text] [Related]
13. Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safety.
Haber P; Iskander J; Walton K; Campbell SR; Kohl KS
Pediatrics; 2011 May; 127 Suppl 1():S39-44. PubMed ID: 21502243
[TBL] [Abstract][Full Text] [Related]
14. A systematic review of adverse events following immunization during pregnancy and the newborn period.
Fulton TR; Narayanan D; Bonhoeffer J; Ortiz JR; Lambach P; Omer SB
Vaccine; 2015 Nov; 33(47):6453-65. PubMed ID: 26413879
[TBL] [Abstract][Full Text] [Related]
15. Progress in Immunization Safety Monitoring - Worldwide, 2020-2022.
Blau EF; Balakrishnan MR; Sköld H; Santhana Gopala Krishnan RS; Lundquist P; Pal S; Gidudu JF
MMWR Morb Mortal Wkly Rep; 2023 Dec; 72(49):1321-1326. PubMed ID: 38060432
[TBL] [Abstract][Full Text] [Related]
16. Disease-specific adverse events following nonlive vaccines: a paradoxical placebo effect or a nocebo phenomenon?
Okaïs C; Gay C; Seon F; Buchaille L; Chary E; Soubeyrand B
Vaccine; 2011 Aug; 29(37):6321-6. PubMed ID: 21627976
[TBL] [Abstract][Full Text] [Related]
17. Active surveillance of adverse events following childhood immunization in Singapore.
Thoon KC; Soh SB; Liew WK; Gunachandran A; Tan NW; Chong CY; Yung CF
Vaccine; 2014 Sep; 32(39):5000-5. PubMed ID: 25045811
[TBL] [Abstract][Full Text] [Related]
18. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
[TBL] [Abstract][Full Text] [Related]
19. The development of standardized case definitions and guidelines for adverse events following immunization.
Kohl KS; Gidudu J; Bonhoeffer J; Braun MM; Buettcher M; Chen RT; Drammeh B; Duclos P; Heijbel H; Heininger U; Hummelman E; Jefferson T; Keller-Stanislawski B; Loupi E; Marcy SM
Vaccine; 2007 Aug; 25(31):5671-4. PubMed ID: 17400339
[No Abstract] [Full Text] [Related]
20. [Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].
Yaméogo TM; Breugelmans JG; Kambou JL; Badolo O; Tiendrebéogo S; Traoré E; Avokey F; Yactayo S
Med Trop (Mars); 2009 Aug; 69(4):320-1. PubMed ID: 19725376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
